Shin‐ichi Yamasaki

No ORCID on file · 2 papers in corpus · active 2001-2003

Study types

  • article 2

Condition tags

  • endometriosis 2
  • adenomyosis 2
article 2003
A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice.
Anticancer research

The inhibitory effects of a novel matrix metalloproteinase inhibitor, ONO-4817, on the development of mammary tumors and the progression of uterine adenomyosis were examined in SHN mice. First, multiparous mice which developed mammary tumor…

article 2001
Suppression of the Development of Experimentally Induced Uterine Adenomyosis by a Novel Matrix Metalloproteinase Inhibitor, ONO-4817, in Mice
Experimental biology and medicine (Maywood, N.J.) ·doi:10.1177/153537020122600506

The inhibitory effects of a novel, orally active matrix metalloproteinase (MMP) inhibitor, ONO-4817, on the development of uterine adenomyosis induced experimentally by pituitary grafting were examined in mice. Mice were given transplants o…